Header Logo

Connection

Joan Lo to Aged

Back to Details
This is a "connection" page, showing publications Joan Lo has written about Aged.
Joan Lo
Connection Strength
2.683
Aged
  1. Prevalence of sleep-related problems and risks in a community-dwelling older adult population: a cross-sectional survey-based study. BMC Public Health. 2022 11 08; 22(1):2045.
    View in: PubMed
    Score: 0.101
  2. Description of Major Osteoporotic Fractures in Women with Invasive Breast Cancer Who Received Endocrine Therapy. JAMA Netw Open. 2021 11 01; 4(11):e2133861.
    View in: PubMed
    Score: 0.094
  3. Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years. BMC Musculoskelet Disord. 2020 Dec 03; 21(1):801.
    View in: PubMed
    Score: 0.088
  4. Bone Mineral Density in Older U.S. Filipino, Chinese, Japanese, and White Women. J Am Geriatr Soc. 2020 11; 68(11):2656-2661.
    View in: PubMed
    Score: 0.087
  5. How Should We Counsel Asian Americans about Fracture Risk? J Am Geriatr Soc. 2020 07; 68(7):1613-1614.
    View in: PubMed
    Score: 0.085
  6. The Epidemiology of Metatarsal Fractures Among Older Females With Bisphosphonate Exposure. J Foot Ankle Surg. 2020 Mar - Apr; 59(2):269-273.
    View in: PubMed
    Score: 0.084
  7. Aggregation of Asian-American subgroups masks meaningful differences in health and health risks among Asian ethnicities: an electronic health record based cohort study. BMC Public Health. 2019 Nov 25; 19(1):1551.
    View in: PubMed
    Score: 0.082
  8. Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure. Osteoporos Int. 2019 Dec; 30(12):2515-2520.
    View in: PubMed
    Score: 0.081
  9. Vitamin D Status Among Older Women Initiating Osteoporosis Therapy. J Am Geriatr Soc. 2019 10; 67(10):2207-2208.
    View in: PubMed
    Score: 0.081
  10. Using Pharmacy Data and Adherence to Define Long-Term Bisphosphonate Exposure in Women. J Manag Care Spec Pharm. 2019 Jun; 25(6):719-723.
    View in: PubMed
    Score: 0.079
  11. Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat. 2018 Apr; 168(2):523-530.
    View in: PubMed
    Score: 0.072
  12. Contemporary rates and correlates of statin use and adherence in nondiabetic adults with cardiovascular risk factors: The KP CHAMP study. Am Heart J. 2017 Dec; 194:25-38.
    View in: PubMed
    Score: 0.070
  13. Predicting Adherence and Persistence with Oral Bisphosphonate Therapy in an Integrated Health Care Delivery System. J Manag Care Spec Pharm. 2017 Apr; 23(4):503-512.
    View in: PubMed
    Score: 0.068
  14. Thyroid function in end stage renal disease and effects of frequent hemodialysis. Hemodial Int. 2017 10; 21(4):534-541.
    View in: PubMed
    Score: 0.068
  15. Changing Patterns in Oral Bisphosphonate Initiation in Women between 2004 and 2012. J Am Geriatr Soc. 2017 03; 65(3):656-658.
    View in: PubMed
    Score: 0.068
  16. Applying ethnic-specific bone mineral density T-scores to Chinese women in the USA. Osteoporos Int. 2016 12; 27(12):3477-3484.
    View in: PubMed
    Score: 0.065
  17. The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy. Bone. 2016 Apr; 85:142-7.
    View in: PubMed
    Score: 0.063
  18. Trends in mortality following hip fracture in older women. Am J Manag Care. 2015 Mar 01; 21(3):e206-14.
    View in: PubMed
    Score: 0.059
  19. Racial/ethnic differences in hip and diaphyseal femur fractures. Osteoporos Int. 2014 Sep; 25(9):2313-8.
    View in: PubMed
    Score: 0.056
  20. Clinical characteristics, bone mineral density and non-vertebral osteoporotic fracture outcomes among post-menopausal U.S. South Asian Women. Bone. 2012 Dec; 51(6):1025-8.
    View in: PubMed
    Score: 0.050
  21. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy. Bone. 2012 Sep; 51(3):524-7.
    View in: PubMed
    Score: 0.049
  22. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes. J Oral Maxillofac Surg. 2012 Aug; 70(8):1844-53.
    View in: PubMed
    Score: 0.049
  23. Clinical correlates of atypical femoral fracture. Bone. 2012 Jul; 51(1):181-4.
    View in: PubMed
    Score: 0.048
  24. The impact of subtrochanteric fracture criteria on hip fracture classification. Osteoporos Int. 2012 Feb; 23(2):743-50.
    View in: PubMed
    Score: 0.045
  25. Oral health considerations in older women receiving oral bisphosphonate therapy. J Am Geriatr Soc. 2011 May; 59(5):916-22.
    View in: PubMed
    Score: 0.045
  26. Fracture risk tool validation in an integrated healthcare delivery system. Am J Manag Care. 2011 Mar; 17(3):188-94.
    View in: PubMed
    Score: 0.045
  27. Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure. J Oral Maxillofac Surg. 2010 Sep; 68(9):2232-40.
    View in: PubMed
    Score: 0.043
  28. Characteristics of implant failures in patients with a history of oral bisphosphonate therapy. J Oral Maxillofac Surg. 2010 Mar; 68(3):508-14.
    View in: PubMed
    Score: 0.042
  29. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg. 2010 Feb; 68(2):243-53.
    View in: PubMed
    Score: 0.041
  30. GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD. Am J Kidney Dis. 2007 Oct; 50(4):552-8.
    View in: PubMed
    Score: 0.035
  31. Persistence with weekly alendronate therapy among postmenopausal women. Osteoporos Int. 2006; 17(6):922-8.
    View in: PubMed
    Score: 0.032
  32. Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen. Breast Cancer Res Treat. 2016 Apr; 156(2):379-89.
    View in: PubMed
    Score: 0.032
  33. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278.
    View in: PubMed
    Score: 0.030
  34. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 2005 Mar; 67(3):1047-52.
    View in: PubMed
    Score: 0.030
  35. Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):32-41.
    View in: PubMed
    Score: 0.025
  36. Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system. Breast Cancer Res Treat. 2012 Sep; 135(2):591-602.
    View in: PubMed
    Score: 0.025
  37. Change in physical activity during active treatment in a prospective study of breast cancer survivors. Breast Cancer Res Treat. 2012 Jan; 131(2):679-90.
    View in: PubMed
    Score: 0.023
  38. Bisphosphonate Treatment Beyond 5 Years and Hip Fracture Risk in Older Women. JAMA Netw Open. 2020 12 01; 3(12):e2025190.
    View in: PubMed
    Score: 0.022
  39. A practical method for collecting food record data in a prospective cohort study of breast cancer survivors. Am J Epidemiol. 2010 Dec 01; 172(11):1315-23.
    View in: PubMed
    Score: 0.022
  40. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010 Oct 10; 28(29):4410-6.
    View in: PubMed
    Score: 0.022
  41. Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat. 2010 Sep; 123(2):507-24.
    View in: PubMed
    Score: 0.021
  42. Determinants of Oral Bisphosphonate Use Beyond 5 Years. J Manag Care Spec Pharm. 2020 Feb; 26(2):197-202.
    View in: PubMed
    Score: 0.021
  43. Statin Therapy and Risk of Incident Diabetes Mellitus in Adults With Cardiovascular Risk Factors. Am J Cardiol. 2020 02 15; 125(4):534-541.
    View in: PubMed
    Score: 0.020
  44. Identifying Key Risk Factors for Dizziness Handicap in Middle-Aged and Older People. J Am Med Dir Assoc. 2020 03; 21(3):344-350.e2.
    View in: PubMed
    Score: 0.020
  45. The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer. Cancer Causes Control. 2019 Feb; 30(2):187-193.
    View in: PubMed
    Score: 0.019
  46. Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. J Clin Oncol. 2009 Feb 20; 27(6):919-26.
    View in: PubMed
    Score: 0.019
  47. Reducing the burden of dizziness in middle-aged and older people: A multifactorial, tailored, single-blind randomized controlled trial. PLoS Med. 2018 07; 15(7):e1002620.
    View in: PubMed
    Score: 0.019
  48. Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat. 2008 Jun; 109(3):573-9.
    View in: PubMed
    Score: 0.017
  49. NSAIDs and breast cancer recurrence in a prospective cohort study. Cancer Causes Control. 2007 Aug; 18(6):613-20.
    View in: PubMed
    Score: 0.017
  50. Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer. Cancer Causes Control. 2017 Jun; 28(6):557-562.
    View in: PubMed
    Score: 0.017
  51. Racial-Ethnic Differences in Fall Prevalence among Older Women: A Cross-Sectional Survey Study. BMC Geriatr. 2017 03 11; 17(1):65.
    View in: PubMed
    Score: 0.017
  52. Tailored multifactorial intervention to improve dizziness symptoms and quality of life, balance and gait in dizziness sufferers aged over 50 years: protocol for a randomised controlled trial. BMC Geriatr. 2017 02 15; 17(1):56.
    View in: PubMed
    Score: 0.017
  53. Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study. Breast Cancer Res Treat. 2016 08; 159(1):119-29.
    View in: PubMed
    Score: 0.016
  54. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population. J Am Coll Cardiol. 2016 05 10; 67(18):2118-2130.
    View in: PubMed
    Score: 0.016
  55. Retinopathy and the risk of cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort study). Am J Cardiol. 2015 Nov 15; 116(10):1527-33.
    View in: PubMed
    Score: 0.015
  56. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
    View in: PubMed
    Score: 0.015
  57. Bone health history in breast cancer patients on aromatase inhibitors. PLoS One. 2014; 9(10):e111477.
    View in: PubMed
    Score: 0.014
  58. Retinopathy and progression of CKD: The CRIC study. Clin J Am Soc Nephrol. 2014 Jul; 9(7):1217-24.
    View in: PubMed
    Score: 0.014
  59. Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study. J Ren Nutr. 2014 May; 24(3):186-93.
    View in: PubMed
    Score: 0.014
  60. Physical performance and frailty in chronic kidney disease. Am J Nephrol. 2013; 38(4):307-15.
    View in: PubMed
    Score: 0.013
  61. FGF23 modifies the relationship between vitamin D and cardiac remodeling. Circ Heart Fail. 2013 Jul; 6(4):817-24.
    View in: PubMed
    Score: 0.013
  62. Patient-physician interaction and quality of life in recently diagnosed breast cancer patients. Breast Cancer Res Treat. 2013 Jun; 139(2):581-95.
    View in: PubMed
    Score: 0.013
  63. Treatment of vitamin D deficiency within a large integrated health care delivery system. J Manag Care Pharm. 2012 Sep; 18(7):497-505.
    View in: PubMed
    Score: 0.012
  64. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2012 Apr; 132(2):729-39.
    View in: PubMed
    Score: 0.012
  65. Methods for assessing fracture risk prediction models: experience with FRAX in a large integrated health care delivery system. J Clin Densitom. 2011 Oct-Dec; 14(4):407-15.
    View in: PubMed
    Score: 0.012
  66. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 2011 Jun 15; 305(23):2432-9.
    View in: PubMed
    Score: 0.011
  67. Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2011 Nov; 130(1):195-205.
    View in: PubMed
    Score: 0.011
  68. Prevalence of ocular fundus pathology in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010 May; 5(5):867-73.
    View in: PubMed
    Score: 0.010
  69. Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res. 2009; 11(3):R31.
    View in: PubMed
    Score: 0.010
  70. Plasma leptin levels and coronary artery calcification in older adults. J Clin Endocrinol Metab. 2007 Feb; 92(2):729-32.
    View in: PubMed
    Score: 0.008
  71. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA. 2006 Nov 01; 296(17):2105-11.
    View in: PubMed
    Score: 0.008
  72. Value of the sagittal abdominal diameter in coronary heart disease risk assessment: cohort study in a large, multiethnic population. Am J Epidemiol. 2006 Dec 15; 164(12):1150-9.
    View in: PubMed
    Score: 0.008
  73. The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol. 2003 Jul; 14(7 Suppl 2):S148-53.
    View in: PubMed
    Score: 0.007

© 2024 Kaiser Permanente